These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32584821)

  • 1. Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey.
    Balachandra S; Rogers JH; Ruangtragool L; Radin E; Musuka G; Oboho I; Paulin H; Parekh B; Birhanu S; Takarinda KC; Hakim A; Apollo T
    PLoS One; 2020; 15(6):e0230205. PubMed ID: 32584821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
    Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
    AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
    PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling.
    Harris TG; Wu Y; Parmley LE; Musuka G; Mapingure MP; Chingombe I; Mugurungi O; Hakim A; Gozhora P; Miller SS; Lamb MR; Samba C; Rogers JH
    Lancet HIV; 2022 Mar; 9(3):e182-e201. PubMed ID: 35150606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
    Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
    PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of HIV viral load testing services in Zimbabwe: Secondary data analyses using data from health facilities using the electronic Patient Monitoring System.
    Apollo T; Takarinda KC; Phillips A; Ndhlovu C; Cowan FM
    PLoS One; 2021; 16(1):e0245720. PubMed ID: 33481931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
    Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
    Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of HIV population viral load in twelve sub-Saharan African countries.
    Hladik W; Stupp P; McCracken SD; Justman J; Ndongmo C; Shang J; Dokubo EK; Gummerson E; Koui I; Bodika S; Lobognon R; Brou H; Ryan C; Brown K; Nuwagaba-Biribonwoha H; Kingwara L; Young P; Bronson M; Chege D; Malewo O; Mengistu Y; Koen F; Jahn A; Auld A; Jonnalagadda S; Radin E; Hamunime N; Williams DB; Kayirangwa E; Mugisha V; Mdodo R; Delgado S; Kirungi W; Nelson L; West C; Biraro S; Dzekedzeke K; Barradas D; Mugurungi O; Balachandra S; Kilmarx PH; Musuka G; Patel H; Parekh B; Sleeman K; Domaoal RA; Rutherford G; Motsoane T; Bissek AZ; Farahani M; Voetsch AC
    PLoS One; 2023; 18(6):e0275560. PubMed ID: 37363921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study.
    Manaye GA; Abateneh DD; Asmare WN; Abebe M
    Medicine (Baltimore); 2021 Nov; 100(47):e27624. PubMed ID: 34964727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey.
    Conan N; Coulborn RM; Simons E; Mapfumo A; Apollo T; Garone DB; Casas EC; Puren AJ; Chihana ML; Maman D
    J Int AIDS Soc; 2020 Sep; 23(9):e25613. PubMed ID: 32969602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intersecting Epidemics: The Predictors of Continued Utilization of HIV Care and Treatment Services During the COVID-19 Outbreak Among People Living with HIV in ZIMBABWE.
    Tapera T; Odimegwu C; Makoni T; Mukuwapasi W; Chitiyo V; Kadziyanike G; Willis N; Mutsinze A; Mawodzeke M; Chimberengwa P; Phiri M
    AIDS Behav; 2024 Oct; 28(Suppl 1):34-46. PubMed ID: 37861922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes Over Time in the Proportion of Advanced HIV Disease in Two High HIV Prevalence Settings in Ndhiwa (Kenya) and Eshowe (South Africa).
    Chihana M; Conan N; Ohler L; Huerga H; Wanjala S; Masiku C; Szumilin E; Ellman T; Etard JF; Maman D; Davies MA
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241260219. PubMed ID: 38881294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    Leeme TB; Mine M; Lechiile K; Mulenga F; Mosepele M; Mphoyakgosi T; Muthoga C; Ngidi J; Nkomo B; Ramaabya D; Tau M; Tenforde MW; Hayes R; Jarvis JN
    HIV Med; 2021 Jan; 22(1):1-10. PubMed ID: 32876378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.